AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $207,000 | – | 6,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SANDERS MORRIS HARRIS LLC | 537,960 | $8,989,000 | 4.37% |
| Burrage Capital Management LLC | 332,546 | $5,557,000 | 3.89% |
| Palo Alto Investors LP | 3,318,212 | $55,447,000 | 3.33% |
| Asymmetry Capital Management, L.P. | 100,544 | $1,680,000 | 1.29% |
| Samsara BioCapital, LLC | 232,571 | $3,886,000 | 1.25% |
| Eventide Asset Management | 3,193,117 | $53,357,000 | 1.16% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,093,144 | $18,266,000 | 0.78% |
| ARMISTICE CAPITAL, LLC | 924,000 | $15,440,000 | 0.68% |
| Values First Advisors, Inc. | 34,962 | $584,000 | 0.58% |
| Bullseye Asset Management LLC | 57,989 | $969,000 | 0.52% |